{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:15:46Z","timestamp":1766182546869,"version":"3.48.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jfma.2025.10.040","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:55:02Z","timestamp":1762206902000},"page":"S84-S89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["Current status and unmet needs of pediatric HCV infection in Taiwan"],"prefix":"10.1016","volume":"124","author":[{"given":"Kai-Chi","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hwei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jfma.2025.10.040_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","article-title":"Hepatitis C virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.040_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12889-023-14995-3","article-title":"Gender differences in risk exposures for acute hepatitis C infection in Taiwan: a nationwide case-control study","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0929-6646(09)60231-X","article-title":"Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants","volume":"106","author":"Chen","year":"2007","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12072-015-9629-x","article-title":"A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan","volume":"9","author":"Bennett","year":"2015","journal-title":"Hepatol Int"},{"issue":"13","key":"10.1016\/j.jfma.2025.10.040_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000690","article-title":"Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan","volume":"94","author":"Yu","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0950268801006148","article-title":"Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies","volume":"127","author":"Huang","year":"2001","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0168-8278(05)80353-8","article-title":"Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection","volume":"20","author":"Ni","year":"1994","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1203\/00006450-199602000-00022","article-title":"Hepatitis C viral infection in thalassemic children: clinical and molecular studies","volume":"39","author":"Ni","year":"1996","journal-title":"Pediatr Res"},{"issue":"12","key":"10.1016\/j.jfma.2025.10.040_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1056\/NEJM199909163411202","article-title":"Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening","volume":"341","author":"Vogt","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.040_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1440-1754.1994.tb00731.x","article-title":"Post-transfusion chronic hepatitis C in children","volume":"30","author":"Matsuoka","year":"1994","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"10.1016\/j.jfma.2025.10.040_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF01957724","article-title":"Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis","volume":"151","author":"Resti","year":"1992","journal-title":"Eur J Pediatr"},{"issue":"9089","key":"10.1016\/j.jfma.2025.10.040_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(97)05413-5","article-title":"Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation","volume":"350","author":"Darby","year":"1997","journal-title":"Lancet"},{"issue":"5 Pt 1","key":"10.1016\/j.jfma.2025.10.040_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3476(05)81359-9","article-title":"Posttransfusion hepatitis C virus infection in children","volume":"124","author":"Ni","year":"1994","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.040_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib16","first-page":"368","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"19","author":"Chang","year":"1996","journal-title":"Clin Invest Med"},{"issue":"8945","key":"10.1016\/j.jfma.2025.10.040_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(95)90277-5","article-title":"Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission","volume":"345","author":"Zanetti","year":"1995","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jmv.21437","article-title":"Perinatal transmission of hepatitis C virus infection","volume":"81","author":"Indolfi","year":"2009","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.jfma.2025.10.040_bib19","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1086\/497701","article-title":"Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy","volume":"192","author":"Mast","year":"2005","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1440-1746.1998.tb00685.x","article-title":"Chronic hepatitis virus infection in children","volume":"13","author":"Chang","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib21","first-page":"570","article-title":"Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study","volume":"33","author":"Ceci","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/315883","article-title":"Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody","volume":"182","author":"Okamoto","year":"2000","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jmv.2202","article-title":"Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors","volume":"67","author":"Dal Molin","year":"2002","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7204a1","article-title":"CDC recommendations for hepatitis C testing among perinatally exposed infants and children - united States, 2023","volume":"72","author":"Panagiotakopoulos","year":"2023","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"9233","key":"10.1016\/j.jfma.2025.10.040_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.040_bib26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jpeds.2013.06.077","article-title":"Perinatal transmission of hepatitis C virus","volume":"163","author":"Indolfi","year":"2013","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510310328","article-title":"Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women","volume":"31","author":"Conte","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib28","article-title":"Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission","volume":"2006","author":"McIntyre","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/516102","article-title":"Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children","volume":"25","author":"Tovo","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.040_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2893.1997.00073.x","article-title":"Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission","volume":"4","author":"Spencer","year":"1997","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/jhep.2001.25885","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"34","author":"Yeung","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1651-2227.2005.tb01916.x","article-title":"Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers","volume":"94","author":"England","year":"2005","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the Study of liver diseases-infectious diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.10.040_bib34","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"25","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"year":"2018","series-title":"Polymerase chain reaction (PCR) for detection of vertically-acquired hepatitis C virus (HCV) infection in early infancy","author":"Honegger","key":"10.1016\/j.jfma.2025.10.040_bib35"},{"issue":"9","key":"10.1016\/j.jfma.2025.10.040_bib36","doi-asserted-by":"crossref","first-page":"e3340","DOI":"10.1093\/cid\/ciaa949","article-title":"Nucleic acid testing for diagnosis of perinatally acquired hepatitis C virus infection in early infancy","volume":"73","author":"Gowda","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.040_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/430601","article-title":"Three broad modalities in the natural history of vertically acquired hepatitis C virus infection","volume":"41","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciac255","article-title":"Spontaneous clearance of vertically acquired hepatitis C infection: implications for testing and treatment","volume":"76","author":"Ades","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"10031","key":"10.1016\/j.jfma.2025.10.040_bib39","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(16)00085-4","article-title":"Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child","volume":"387","author":"Indolfi","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jfma.2025.10.040_bib40","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/497141","article-title":"Chronic hepatitis C in childhood: an 18-year experience","volume":"41","author":"Iorio","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1086\/345908","article-title":"Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children","volume":"36","author":"Jara","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.040_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.20030","article-title":"Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth","volume":"39","author":"Casiraghi","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.mpg.0000228117.52229.32","article-title":"Hepatitis C in children: a quaternary referral center perspective","volume":"43","author":"Rumbo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.jfma.2025.10.040_bib44","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1053\/j.gastro.2008.02.082","article-title":"Italian Observatory for HCV Infection and Hepatitis C in Children. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease","volume":"134","author":"Bortolotti","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jfma.2025.10.040_bib45","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1572-0241.2006.00918.x","article-title":"Liver steatosis in children with chronic hepatitis C","volume":"101","author":"Guido","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.22094","article-title":"Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial","volume":"47","author":"Goodman","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpeds.2006.11.037","article-title":"Clinical spectrum and histopathologic features of chronic hepatitis C infection in children","volume":"150","author":"Mohan","year":"2007","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib48","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.26519","article-title":"Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study","volume":"58","author":"Mohan","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jfma.2025.10.040_bib49","first-page":"1225","article-title":"Histopathology of hepatitis C in children, a systematic review: implications for treatment","volume":"13","author":"Indolfi","year":"2015","journal-title":"Guido M Infect Ther"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib50","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1572-0241.2003.07293.x","article-title":"Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?","volume":"98","author":"Guido","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jfma.2025.10.040_bib51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/cid\/cis1031","article-title":"Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis","volume":"56","author":"Druyts","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.040_bib52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/QCO.0000000000000856","article-title":"Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children","volume":"35","author":"Honegger","year":"2022","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hep.29278","article-title":"Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection","volume":"66","author":"Wirth","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.040_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.30821","article-title":"Sofosbuvir and Ribavirin Therapy for children aged 3 to <12 years with Hepatitis C Virus Genotype 2 or 3 infection","volume":"71","author":"Rosenthal","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/hep.28995","article-title":"The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection","volume":"66","author":"Balistreri","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.040_bib56","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/hep.30123","article-title":"Safety and efficacy of Ledipasvir-Sofosbuvir with or without ribavirin for chronic hepatitis C in children ages 6-11","volume":"68","author":"Murray","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib57","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.30830","article-title":"Ledipasvir-Sofosbuvir for 12 weeks in children 3 to <6 years old with chronic hepatitis C","volume":"71","author":"Schwarz","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/liv.15827","article-title":"Efficacy and safety of DAA in children and adolescents with chronic HCV infection: a systematic review and meta-analysis","volume":"44","author":"Indolfi","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2025.10.040_bib60","series-title":"The Liver Meeting 2019","article-title":"Cost-utility analysis of treatment of chronic paediatric hepatitis C with new direct-acting antivirals [abstract 1619]","author":"Greenway","year":"2019"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib61","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1746.2007.04859.x","article-title":"Health-related quality of life in children with hepatitis C acquired in the first year of life","volume":"23","author":"Nydegger","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.040_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MPG.0b013e318185998f","article-title":"Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes","volume":"48","author":"Rodrigue","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib63","first-page":"1214","article-title":"Health-related quality of life (HRQOL) in children with chronic liver disease in North East Iran using PedsQL\u2122 4.0","volume":"7","author":"Tehranian","year":"2015","journal-title":"Electron Physician"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.040_bib64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.30840","article-title":"Pharmacokinetics, safety, and efficacy of Glecaprevir\/Pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA Study","volume":"71","author":"Jonas","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.040_bib65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MPG.0000000000001754","article-title":"Health-related quality of life in adolescent patients with hepatitis C genotype 1 treated with Sofosbuvir and Ledipasvir","volume":"66","author":"Younossi","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jvh.12830","article-title":"Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin","volume":"25","author":"Younossi","year":"2018","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib67","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2468-1253(23)00408-9","article-title":"WHO hepatitis C elimination targets: the global equity challenge","volume":"9","author":"Heath","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.040_bib68","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11901-010-0060-4","article-title":"Current concepts of HBV\/HCV coinfection: coexistence, but not necessarily in harmony","volume":"9","author":"Jamma","year":"2010","journal-title":"Curr Hepat Rep"},{"issue":"11\u201312","key":"10.1016\/j.jfma.2025.10.040_bib69","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.14352","article-title":"French Anrs Co22 Hepather Cohort. The negative impact of HBV\/HCV coinfection on cirrhosis and its consequences","volume":"46","author":"Pol","year":"2017","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625005856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625005856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:58:52Z","timestamp":1766159932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625005856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":67,"alternative-id":["S0929664625005856"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.10.040","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status and unmet needs of pediatric HCV infection in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}